U.S. stock futures declined early Wednesday following U.S. "self-defense strikes" against Iran, in retaliation for a downed helicopter. Asian markets also opened lower.
News Raise
A new study suggests glucosamine, a common supplement for joint pain, may accelerate memory loss in individuals with Alzheimer's disease and mild cognitive impairment.
SpaceX is poised for its public debut, aiming to raise $75 billion at a $1.75 trillion valuation, making it the largest IPO on record. The company has set its listing price at $135 per share.
NASA has announced the four astronauts selected for the Artemis III mission, marking a significant step in the agency's plan to return humans to the lunar surface and conduct advanced training for the complex mission.
A new drug, apitegromab, is showing promise in preserving lean muscle mass for individuals undergoing significant weight loss, particularly those using popular 'slimming jabs' like tirzepatide.
Lessons from the tobacco industry's playbook on addiction and marketing are being applied to understand and potentially combat the widespread consumption of ultra-processed foods.
Emerging research suggests that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may also offer a protective effect against certain cancers. Scientists are actively investigating the underlying mechanisms.
Rivian has commenced deliveries of its highly anticipated R2 SUV, a model seen as pivotal for the electric vehicle manufacturer's future growth and market positioning.
SpaceX's potential Initial Public Offering is reportedly experiencing significant investor interest, with demand approaching four times the number of shares available, according to a source familiar with the matter.
Major U.S. stock indices, including the S&P 500 and Nasdaq, closed lower as an anticipated rebound in semiconductor stocks failed to materialize, contributing to a broader market downturn.